|
Jun 23, 2025 |
iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing
|
PDF
|
|
Jun 17, 2025 |
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
|
PDF
|
|
May 19, 2025 |
Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology
|
PDF
|
|
May 12, 2025 |
Oncocyte Reports Q1 2025 Results and Business Progress
|
PDF
|
|
May 07, 2025 |
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
|
PDF
|
|
Apr 30, 2025 |
Oncocyte Provides Positive Update on Clinical Trial Progress
|
PDF
|
|
Apr 29, 2025 |
Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity
|
PDF
|
|
Apr 02, 2025 |
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
|
PDF
|
|
Mar 24, 2025 |
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
|
PDF
|
|
Mar 18, 2025 |
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
|
PDF
|